CompletedNCT03732248
Rapamycin and Responses to Alcohol Cues
About this title
Read the official source — NCT03732248Medication studyAges 18+United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: from 18 years.
- Listed locations
- CharlestonSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Study information
Study start dateStarted: July 12, 2018
- Recruitment status
- Completed
- Enrollment listed in the registry
- 21
- Sponsor
- Medical University of South Carolina
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT03732248
- Official title
Show the full official title
Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders: A Translational Clinical Neuroscience Pilot Investigation of a Novel Pharmacological Agent
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedCharleston
Questions about this study
Who is behind this study?
The study sponsor is Medical University of South Carolina, a university.
Did this study involve medication?
Yes. The study involved medication, including Rapamycin and Placebo.
Who was this study for?
Listed age limits: from 18 years.
